24 March 2021

Radboudumc researchers, Roderick Maas and Bart van de Warrenburg, theme Disorders of movement, evaluated health-related quality of life, depressive symptoms, fatigue, and physical activity in mildly to moderately affected patients with SCA3, which is the most common inherited spinocerebellar ataxia (SCA) type worldwide. Specifically, they aimed to examine the relationships between patient-reported outcome measures (PROMs) and objective, clinician-based disease severity measures. The results of this study, which was conducted at the Radboudumc Expert Center for Rare and Genetic Movement Disorders, have been published in The Cerebellum on 10 March 2021.

There are exciting therapeutic developments for a number of rare genetic movement disorders, including the dominantly SCAs. Urgent work is needed to reach actual trial-readiness for these disorders. One of the principal dilemmas involves the choice of relevant endpoints that capture meaningful changes in gradually progressive conditions. Commonly used outcome measures include ratings of disease severity by physicians, but these will likely not reflect the actual difficulties patients are facing in daily life. There is currently an increasing interest in PROMs which provide valuable insights into self-perceived health status. PROMs need to be carefully studied, in particular in the early disease stages.

SCA3 patients reported lower quality of life, more depressive symptoms, and higher levels of fatigue than healthy controls. The amount of physical activity did not differ between both groups. Quality of life was primarily determined by fatigue and not by ataxia severity. Depressive symptoms were related to disease duration and fatigue but not to markers of motor disease progression.

Taken together, in early-stage SCA3 patients, decreased quality of life, increased levels of fatigue, and a higher number of depressive symptoms do not merely reflect motor impairment as captured by the commonly used rating scales. The observed discordance between patient-reported and clinician-based outcomes indicates that these measures genuinely evaluate distinct aspects of disease and emphasizes their complementariness in therapeutic trials.


Maas RPPWM, Schutter DJLG, van de Warrenburg BPC. Discordance Between Patient-Reported Outcomes and Physician-Rated Motor Symptom Severity in Early-to-Middle-Stage Spinocerebellar Ataxia Type 3. Cerebellum. 2021 Mar 10. doi: 10.1007/s12311-021-01252-9.

Related news items

Patients who are obese or overweight are at risk for a more severe course of COVID-19

19 April 2021

International study shows risk of mortality does not increase

read more

New way of diagnostics detects 'undetectable' genetic defects

15 April 2021

Research provides guidance for global application

read more

Vici grant for Michiel Vermeulen Reading the epitranscriptome

15 April 2021

Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a Vici grant from the Netherlands Organisation for Scientific Research (NWO), one of the largest personal scientific awards in the Netherlands.

read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021

The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period.

read more

COVID-19 regulations for nursing homes have varying effects

14 April 2021

On May 11th 2020, the Dutch Government allowed 26 nursing homes to welcome one visitor per resident, after two months of lockdown. An in-depth Radboudumc study monitored the feasibility of the regulations and the impact on the well-being of residents, their visitors, and healthcare staff.

read more